HSV-Tk engineered donor lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HSV-Tk engineered donor lymphocytes, covering 2021-06-22 to 2021-06-22. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy Study on the Strategy of HSV-Tk Engineering Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia [Phase 3]